Home/Cellectar Biosciences/Chad Kolean

CK

Chad Kolean

Chief Financial Officer

Cellectar Biosciences

Therapeutic Areas

Oncology Hematologic Malignancies

Cellectar Biosciences Pipeline

Drug	Indication	Phase
Iopofosine I 131 (CLR 131)	Relapsed/Refractory Multiple Myeloma	Phase 3

Leadership Team at Cellectar Biosciences

President, Chief Executive Officer and Director

Chief Operating Officer

View full Cellectar Biosciences profile